Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.
Cellectar Biosciences stock last closed at $2.76, up 2.6% from the previous day, and has decreased 63.71% in one year. It has underperformed other stocks in the Biotechnology industry by 0.29 percentage points. Cellectar Biosciences stock is currently +12.65% from its 52-week low of $2.45, and -86.6% from its 52-week high of $20.60.
At the moment, there are 4.24M shares of CLRB outstanding. The market capitalization of CLRB is $11.70M. In the past 24 hours, 27,500 CLRB shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy CLRB shares.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal details so you can buy CLRB stock today.
Now that you have filled out your info on the best stock market app, you need to deposit funds:
Check out the walkthrough below if you need help transferring money into your brokerage account.
After you have identified the best place to buy Cellectar Biosciences stock, it's important to research their stock prior to buying, so you truly understand the risk and opportunity.
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on CLRB's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge CLRB's fair value.
Using relative valuations metrics:
You can do more valuation analysis on CLRB's stock here.
You can dig deeper into what analysts are saying on the Cellectar Biosciences stock forecast page.
In the past year, executives and large shareholders at CLRB have bought more shares than they have sold.
John Neis, Director of CLRB, was the latest CLRB insider to sell. They sold $732.01 worth of CLRB shares on Dec 12, 2025.
Research more about who owns CLRB shares here.
No, Cellectar Biosciences doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main types of orders:
Click the Open button and your broker will place the order.
If you need more help buying stocks on eToro, click the how to video below:
Now that you own some shares in CLRB, you'll want to keep up with your investment.
Add CLRB to a watchlist to get notified of important updates regarding your CLRB stock.
To reiterate, here are the 6 steps to buy Cellectar Biosciences stock:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your new investment in Cellectar Biosciences, click below.